Academic Journal

Aortic valve calcification is promoted by interleukin-8 and restricted through antagonizing CXC motif chemokine receptor 2

التفاصيل البيبلوغرافية
العنوان: Aortic valve calcification is promoted by interleukin-8 and restricted through antagonizing CXC motif chemokine receptor 2
المؤلفون: Dhayni, Kawthar, Chabry, Yuthiline, Hénaut, Lucie, Avondo, Carine, Boudot, Cedric, Ouled-Haddou, Hakim, Bigot-Corbel, Edith, Touati, Gilles, Caus, Thierry, Messaoudi, Hind, Bellien, Jérémy, Tribouilloy, Christophe, Messika-Zeitoun, David, Zibara, Kazem, Kamel, Saïd, Bennis, Youssef
المساهمون: University Hospital, Cardiac Research Network, Aortic VAlve, French Government, National Research Agency
المصدر: Cardiovascular Research ; volume 119, issue 13, page 2355-2367 ; ISSN 0008-6363 1755-3245
بيانات النشر: Oxford University Press (OUP)
سنة النشر: 2023
الوصف: Aims Inflammatory cytokines play a critical role in the progression of calcific aortic valve disease (CAVD), for which there is currently no pharmacological treatment. The aim of this study was to test the hypothesis that interleukin-8 (IL-8), known to be involved in arterial calcification, also promotes aortic valve calcification (AVC) and to evaluate whether pharmacologically blocking the IL-8 receptor, CXC motif chemokine receptor 2 (CXCR2), could be effective in preventing AVC progression. Methods and results A cohort of 195 patients (median age 73, 74% men) diagnosed with aortic valve stenosis (severe in 16.9% of cases) were prospectively followed by CT for a median time of 2.6 years. A Cox proportional hazards regression analysis indicated that baseline IL-8 serum concentrations were associated with rapid progression of AVC, defined as an annualized change in the calcification score by CT ≥ 110 AU/year, after adjustment for age, gender, bicuspid anatomy, and baseline disease severity. In vitro, exposure of primary human aortic valvular interstitial cells (hVICs) to 15 pg/mL IL-8 induced a two-fold increase in inorganic phosphate (Pi)-induced calcification. IL-8 promoted NFκB pathway activation, MMP-12 expression, and elastin degradation in hVICs exposed to Pi. These effects were prevented by SCH527123, an antagonist of CXCR2. The expression of CXCR2 was confirmed in hVICs and samples of aortic valves isolated from patients with CAVD, in which the receptor was mainly found in calcified areas, along with MMP-12 and a degraded form of elastin. Finally, in a rat model of chronic kidney disease-associated CAVD, SCH527123 treatment (1 mg/kg/day given orally for 11 weeks) limited the decrease in aortic cusp separation, the increase in maximal velocity of the transaortic jet, and the increase in aortic mean pressure gradient measured by echocardiography, effects that were associated with a reduction in hydroxyapatite deposition and MMP-12 expression in the aortic valves. Conclusion Overall, these results ...
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1093/cvr/cvad117
DOI: 10.1093/cvr/cvad117/51090218/cvad117.pdf
الاتاحة: https://doi.org/10.1093/cvr/cvad117
https://academic.oup.com/cardiovascres/advance-article-pdf/doi/10.1093/cvr/cvad117/51090218/cvad117.pdf
https://academic.oup.com/cardiovascres/article-pdf/119/13/2355/52460121/cvad117.pdf
Rights: https://academic.oup.com/pages/standard-publication-reuse-rights
رقم الانضمام: edsbas.1B251BD4
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.1B251BD4
961
3
Academic Journal
academicJournal
960.976379394531
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.1B251BD4&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => https://doi.org/10.1093/cvr/cvad117# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Aortic valve calcification is promoted by interleukin-8 and restricted through antagonizing CXC motif chemokine receptor 2 )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Dhayni%2C+Kawthar%22">Dhayni, Kawthar</searchLink><br /><searchLink fieldCode="AR" term="%22Chabry%2C+Yuthiline%22">Chabry, Yuthiline</searchLink><br /><searchLink fieldCode="AR" term="%22Hénaut%2C+Lucie%22">Hénaut, Lucie</searchLink><br /><searchLink fieldCode="AR" term="%22Avondo%2C+Carine%22">Avondo, Carine</searchLink><br /><searchLink fieldCode="AR" term="%22Boudot%2C+Cedric%22">Boudot, Cedric</searchLink><br /><searchLink fieldCode="AR" term="%22Ouled-Haddou%2C+Hakim%22">Ouled-Haddou, Hakim</searchLink><br /><searchLink fieldCode="AR" term="%22Bigot-Corbel%2C+Edith%22">Bigot-Corbel, Edith</searchLink><br /><searchLink fieldCode="AR" term="%22Touati%2C+Gilles%22">Touati, Gilles</searchLink><br /><searchLink fieldCode="AR" term="%22Caus%2C+Thierry%22">Caus, Thierry</searchLink><br /><searchLink fieldCode="AR" term="%22Messaoudi%2C+Hind%22">Messaoudi, Hind</searchLink><br /><searchLink fieldCode="AR" term="%22Bellien%2C+Jérémy%22">Bellien, Jérémy</searchLink><br /><searchLink fieldCode="AR" term="%22Tribouilloy%2C+Christophe%22">Tribouilloy, Christophe</searchLink><br /><searchLink fieldCode="AR" term="%22Messika-Zeitoun%2C+David%22">Messika-Zeitoun, David</searchLink><br /><searchLink fieldCode="AR" term="%22Zibara%2C+Kazem%22">Zibara, Kazem</searchLink><br /><searchLink fieldCode="AR" term="%22Kamel%2C+Saïd%22">Kamel, Saïd</searchLink><br /><searchLink fieldCode="AR" term="%22Bennis%2C+Youssef%22">Bennis, Youssef</searchLink> )
Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => University Hospital<br />Cardiac Research Network<br />Aortic VAlve<br />French Government<br />National Research Agency )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Cardiovascular Research ; volume 119, issue 13, page 2355-2367 ; ISSN 0008-6363 1755-3245 )
Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Oxford University Press (OUP) )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2023 )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Aims Inflammatory cytokines play a critical role in the progression of calcific aortic valve disease (CAVD), for which there is currently no pharmacological treatment. The aim of this study was to test the hypothesis that interleukin-8 (IL-8), known to be involved in arterial calcification, also promotes aortic valve calcification (AVC) and to evaluate whether pharmacologically blocking the IL-8 receptor, CXC motif chemokine receptor 2 (CXCR2), could be effective in preventing AVC progression. Methods and results A cohort of 195 patients (median age 73, 74% men) diagnosed with aortic valve stenosis (severe in 16.9% of cases) were prospectively followed by CT for a median time of 2.6 years. A Cox proportional hazards regression analysis indicated that baseline IL-8 serum concentrations were associated with rapid progression of AVC, defined as an annualized change in the calcification score by CT ≥ 110 AU/year, after adjustment for age, gender, bicuspid anatomy, and baseline disease severity. In vitro, exposure of primary human aortic valvular interstitial cells (hVICs) to 15 pg/mL IL-8 induced a two-fold increase in inorganic phosphate (Pi)-induced calcification. IL-8 promoted NFκB pathway activation, MMP-12 expression, and elastin degradation in hVICs exposed to Pi. These effects were prevented by SCH527123, an antagonist of CXCR2. The expression of CXCR2 was confirmed in hVICs and samples of aortic valves isolated from patients with CAVD, in which the receptor was mainly found in calcified areas, along with MMP-12 and a degraded form of elastin. Finally, in a rat model of chronic kidney disease-associated CAVD, SCH527123 treatment (1 mg/kg/day given orally for 11 weeks) limited the decrease in aortic cusp separation, the increase in maximal velocity of the transaortic jet, and the increase in aortic mean pressure gradient measured by echocardiography, effects that were associated with a reduction in hydroxyapatite deposition and MMP-12 expression in the aortic valves. Conclusion Overall, these results ... )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1093/cvr/cvad117 )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1093/cvr/cvad117/51090218/cvad117.pdf )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.1093/cvr/cvad117<br />https://academic.oup.com/cardiovascres/advance-article-pdf/doi/10.1093/cvr/cvad117/51090218/cvad117.pdf<br />https://academic.oup.com/cardiovascres/article-pdf/119/13/2355/52460121/cvad117.pdf )
Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => https://academic.oup.com/pages/standard-publication-reuse-rights )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.1B251BD4 )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.1093/cvr/cvad117 ) ) [Languages] => Array ( [0] => Array ( [Text] => English ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Aortic valve calcification is promoted by interleukin-8 and restricted through antagonizing CXC motif chemokine receptor 2 [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Dhayni, Kawthar ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Chabry, Yuthiline ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Hénaut, Lucie ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Avondo, Carine ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Boudot, Cedric ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Ouled-Haddou, Hakim ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Bigot-Corbel, Edith ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Touati, Gilles ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Caus, Thierry ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Messaoudi, Hind ) ) ) [10] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Bellien, Jérémy ) ) ) [11] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Tribouilloy, Christophe ) ) ) [12] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Messika-Zeitoun, David ) ) ) [13] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Zibara, Kazem ) ) ) [14] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Kamel, Saïd ) ) ) [15] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Bennis, Youssef ) ) ) [16] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => University Hospital ) ) ) [17] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Cardiac Research Network ) ) ) [18] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Aortic VAlve ) ) ) [19] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => French Government ) ) ) [20] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => National Research Agency ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2023 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-locals [Value] => edsbas ) [1] => Array ( [Type] => issn-locals [Value] => edsbas.oa ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Cardiovascular Research ; volume 119, issue 13, page 2355-2367 ; ISSN 0008-6363 1755-3245 [Type] => main ) ) ) ) ) ) )
IllustrationInfo